Search within:

Kelly McCall, PhD

Kelly McCall
Academic and Research Center 302B, Athens Campus
Diabetes Institute
Specialty Medicine


  • Molecular & Cellular Biology (PhD), Ohio University, 2003
  • Biological Sciences (BS), Ohio University, 1997


  • Toll-like receptors
  • Diabetes mellitus, Type 1 and 2
  • Chronic inflammation
  • Phenylmethimazole (C10)
  • Cancer
  • Atherosclerosis
  • Wnt5a
  • Novel therapeutics
  • Nonalcoholic fatty liver disease
  • Interferon regulatory factor-3
  • Autoimmunity
  • Autoimmune diseases
  • Chronic inflammatory diseases
  • Obesity
  • Mouse models of disease

Summary of Work:     


I study molecular pathways involved in autoimmune/inflammatory diseases (AIDs) & utilize this knowledge to develop novel therapeutics. My work established aberrant toll-like receptor (TLR) expression & signaling in non-immune cells is a key mediator of AIDs; work that initiated a paradigm shift.


View My Work in ResearchGate 

View My Work in the National Center for Biotechnology Information (NCBI)